Any attempts to treat Helicobacter pylori also called H. pylori contagion of the stomach might cause a significant reduction in the possibility of stomach cancer occurrence especially in elderly individuals of 60 years and over. This information is based on the study results presentedduring the 25th UEG Week held in Barcelona . This study was conducted in a population of more than 63000 individuals having received antibiotic-based treatment for Helicobacter pylori (H. pylori) infection. Results of this treatment showed a reduction of 22 percent possibility of suffering stomach cancer at the age of 60 years and above compared to the general population.
This research focused and analyzed the jeopardy of developing gastric/stomach cancer in a sizable group of people who had undergone antibiotic treatment for the H. pylori infection caused by a bacteria found in the stomach lining. Among the people who received this treatment, only 0.8 percent developed stomach cancer with about 1.1 percent of victims in an age-matched general population sample.
Stomach cancer (gastric cancer) is known to be the 4th most extensive killer cancer globally having accounted for approximately 754000 deaths in 2015. The disease commonly affects the old from the age of 60 years an average of 69 years during the time of treatment.
The International Agency for Research on Cancer (IARC) rates H. pylori infection as a carcinogen, and its also known to be the most obvious factor that causes stomach cancer corresponding to 78 percent of the global stomach cancer cases. H. pylori infection is commonly thought to be affecting over 50 percent of the world’s population, even though many people do not notice any signs of the disease until they begin to develop symptoms and signs of gastric irritation like dyspepsia or heartburn. Diagnosis is usually made using blood test or breath test, but sometimes can be done through endoscopy or stool test.
While presenting the results of this study during the Opening Plenary session of the 25th UEG Week in Barcelona, Professor WK Leung from University of Hong Kong(Department of Medicine) said;
“We saw a significantly lower risk of gastric cancer in people over 60 who received antibiotic therapy for their H. pylori infection, in comparison to the general population. The 22% reduction is remarkable, and suggests that there is real value in the treatment of this infection.”
Professor Leung added the concern that the elderly now deserve to be treated to help reduce the chances of developing stomach cancer. He said;
“Although it has been commonly thought that it may be too late to give H. pylori eradication therapy to older subjects, we can now confidently recommend that the H. pylori infection should be treated in the elderly to help reduce their risk of developing gastric cancer.”